Jaimish Gwalani, MD
Pain Management · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Fremont Pain Treamtment Center · 4 clinicians in this group
Looking this up.
Hospitals listed: 559548. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gwalani’s office at (510) 818-9237 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A151701 · Current
Licensed to practise in California · since 2017 · expires 2028-11-30 · Sidney Kimmel Medical College at Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Pain Medicine - Pain Medicine
Original Medicare doctor bills
$99,345
Medicare paid this office $99,345 for 117 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 108 | $23,249 | $78 |
| New patient visit (60+ min) | 48 | $9,219 | $192 |
| Insertion of spinal neurostimulator electrode array through skin | 13 | $9,106 | $268 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 42 | $8,648 | $142 |
| Fluoroscopic guidance for needle placement | 28 | $6,654 | $117 |
See all 14 services
| Short return visit (20+ min) | 108 | $23,249 | $78 |
| New patient visit (60+ min) | 48 | $9,219 | $192 |
| Insertion of spinal neurostimulator electrode array through skin | 13 | $9,106 | $268 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 42 | $8,648 | $142 |
| Fluoroscopic guidance for needle placement | 28 | $6,654 | $117 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 16 | $5,171 | $235 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 24 | $4,239 | $118 |
| Aspiration and/or injection of fluid from large joint | 26 | $3,369 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 24 | $2,284 | $63 |
| Injection of substance into lower spine canal using imaging guidance | 22 | $1,989 | $69 |
| Injection of substance into middle or upper spine canal using imaging guidance | 12 | $1,745 | $92 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 15 | $1,443 | $69 |
| X-ray of lower and sacral spine, 2-3 views | 68 | $1,340 | $9 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $148 | $11 |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 17 | 64 | 60 | 57 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 36 | 48 | 34 | 61 |
| Insertion of spinal neurostimulator electrode array through skin | – | 40 | 26 | 34 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | 27 | 26 | 19 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | – | 34 | 36 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | – | – | 34 | 36 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
117 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 14% · Women 73% · Also on Medicaid 71% · Health risk score 1.29. At or below the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 31% · Depression 31% · Coronary heart disease 23% · Heart failure 18% · COPD 16% · Atrial fibrillation 11% · Dementia 9%.
The office billed $598,800, Medicare allowed $126,725 and paid $99,345; for 1,072 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 117 | 1,072 | 72 | 1.29 | $598,800 | $99,345 |
| 2023 | 118 | 989 | 72 | 1.39 | $441,400 | $79,409 |
| 2022 | 97 | 1,083 | 74 | 1.32 | $446,800 | $89,115 |
| 2021 | 99 | 802 | 71 | 1.28 | $289,185 | $74,936 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 93 | $24,072 | $80 |
| New patient visit (60+ min) | 57 | $9,959 | $175 |
| Insertion of spinal neurostimulator electrode array through skin | 11 | $6,911 | $266 |
| Fluoroscopic guidance for needle placement | 25 | $6,858 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 24 | $4,570 | $134 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 24 | $3,949 | $116 |
| Aspiration and/or injection of fluid from large joint | 25 | $3,528 | $59 |
| Injection of substance into middle or upper spine canal using imaging guidance | 16 | $2,352 | $90 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 24 | $2,176 | $64 |
| Injection of substance into lower spine canal using imaging guidance | 19 | $2,053 | $79 |
| Short return visit (20+ min) | 18 | $1,059 | $56 |
| X-ray of lower and sacral spine, 2-3 views | 55 | $1,016 | $9 |
| Injection, methylprednisolone acetate, 40 mg | 29 | $393 | None |
| X-ray of upper spine, 4-5 views | 17 | $294 | $11 |
2022: 14 services
| Return visit (30+ min) | 72 | $21,496 | $112 |
| Insertion of spinal neurostimulator electrode array through skin | 15 | $10,619 | $265 |
| Short return visit (20+ min) | 61 | $10,289 | $81 |
| New patient visit (60+ min) | 51 | $9,820 | $193 |
| Short return visit (20+ min) | 57 | $7,072 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $6,312 | $132 |
| Short return visit | 31 | $3,785 | $51 |
| Aspiration and/or injection of fluid from large joint | 25 | $3,683 | $58 |
| Injection of substance into middle or upper spine canal using imaging guidance | 16 | $2,465 | $91 |
| Fluoroscopic guidance for needle placement | 13 | $2,264 | $98 |
| X-ray of lower and sacral spine, 2-3 views | 46 | $760 | $9 |
| Injection, methylprednisolone acetate, 40 mg | 30 | $316 | None |
| X-ray of upper spine, 2-3 views | 11 | $179 | $9 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $151 | $11 |
2021: 12 services
| Return visit (30+ min) | 79 | $34,168 | $118 |
| New patient visit (60+ min) | 56 | $11,098 | $198 |
| Return visit (30+ min) | 40 | $5,383 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 30 | $4,651 | $129 |
| Injection of substance into middle or upper spine canal using imaging guidance | 14 | $1,772 | $93 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 26 | $1,293 | $45 |
| Short return visit (20+ min) | 18 | $1,155 | $58 |
| Aspiration and/or injection of fluid from large joint | 12 | $957 | $56 |
| X-ray of lower and sacral spine, minimum of 4 views | 27 | $432 | $11 |
| X-ray of upper spine, 4-5 views | 14 | $222 | $12 |
| X-ray of lower and sacral spine, 2-3 views | 15 | $163 | $10 |
| Injection, methylprednisolone acetate, 40 mg | 20 | $123 | None |
Medicaid work
$99,476 in 2024
Medicaid paid $99,476 for 1,406 billed services this clinician did in 2024, up to 77 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 147 | $65,930 |
| Short return visit (20+ min) | 552 | $21,018 |
| NJX AA&/STRD TFRML EPI LUMBAR/SACRAL EA ADDL | 12 | $6,250 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 61 | $5,189 |
| Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure) | 13 | $688 |
| Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 198 | $260 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 226 | $120 |
| MEASURE BLOOD OXYGEN LEVEL | 197 | $21 |
| 2024 | 1,406 | 8 | 77 | $99,476 |
| 2023 | 1,870 | 8 | 70 | $101,533 |
| 2022 | 618 | 7 | 40 | $30,672 |
| 2021 | 515 | 4 | 39 | $19,248 |
See the largest Medicaid services in earlier years
2023
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 200 | $47,975 |
| Short return visit (20+ min) | 658 | $25,246 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 152 | $14,385 |
| NJX AA&/STRD TFRML EPI LUMBAR/SACRAL EA ADDL | 26 | $7,866 |
| Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 280 | $4,662 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 261 | $1,025 |
| MEASURE BLOOD OXYGEN LEVEL | 281 | $322 |
| Radiologic examination, spine, cervical; 2 or 3 views | 12 | $52 |
2022
| Return visit (30+ min) | 193 | $10,691 |
| Short return visit (20+ min) | 252 | $8,390 |
| Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level | 20 | $6,872 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 58 | $4,019 |
| Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 28 | $488 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 39 | $179 |
| MEASURE BLOOD OXYGEN LEVEL | 28 | $32 |
2021
| Return visit (30+ min) | 450 | $18,599 |
| Short return visit (20+ min) | 19 | $564 |
| X-ray of lumbosacral spine, anteroposterior and lateral views | 14 | $50 |
| MEASURE BLOOD OXYGEN LEVEL | 32 | $34 |
Drugs they prescribed that Part D paid
$6,319
Pharmacies billed $6,319 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (60 of 458) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%.
457 generic and fewer than 11 brand-name prescriptions · $6,319 in drug cost · 19 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 36 | $1,155 | $32 |
| Gabapentin | 90 | $623 | $7 |
| Methocarbamol | 25 | $369 | $15 |
| Diclofenac | 12 | $342 | $28 |
| Cyclobenzaprine | 34 | $294 | $9 |
See all 14 drugs
| Celecoxib | 36 | $1,155 | $32 |
| Gabapentin | 90 | $623 | $7 |
| Methocarbamol | 25 | $369 | $15 |
| Diclofenac | 12 | $342 | $28 |
| Cyclobenzaprine | 34 | $294 | $9 |
| Cephalexin | 17 | $289 | $17 |
| Baclofen | 34 | $252 | $7 |
| Pregabalin | 14 | $165 | $12 |
| Hydrocodone-Acetaminophen | 21 | $155 | $7 |
| Amitriptyline | 22 | $131 | $6 |
| Duloxetine | 15 | $92 | $6 |
| Acetaminophen-Codeine | 22 | $71 | $3 |
| Ibuprofen | 13 | $46 | $4 |
| Tramadol | 14 | $12 | $1 |
Year by year
| 2024 | 458 | 153 | 13% (60) | None | $6,319 |
| 2023 | 235 | 72 | 25% (59) | None | $6,541 |
| 2022 | 219 | 57 | 21% (45) | None | $5,818 |
| 2021 | 75 | 35 | 31% (23) | 16% | $2,547 |
| 2020 | 47 | 30 | None | None | $1,884 |
| 2019 | 428 | 65 | 5% (20) | None | $57,365 |
| 2018 | 465 | 92 | 4% (18) | None | $44,092 |
| 2017 | 22 | 11 | 0% (0) | None | $896 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Diclofenac | 19 | $2,739 | $144 |
| Celecoxib | 21 | $566 | $27 |
| Pregabalin | 20 | $503 | $25 |
| Gabapentin | 36 | $318 | $9 |
| Hydrocodone-Acetaminophen | 17 | $158 | $9 |
| Acetaminophen-Codeine | 28 | $150 | $5 |
| Cyclobenzaprine | 18 | $149 | $8 |
| Tramadol | 14 | $55 | $4 |
2022: 8 drugs
| Diclofenac | 14 | $891 | $64 |
| Celecoxib | 29 | $836 | $29 |
| Pregabalin | 18 | $539 | $30 |
| Gabapentin | 30 | $308 | $10 |
| Cephalexin | 21 | $211 | $10 |
| Cyclobenzaprine | 14 | $188 | $13 |
| Hydrocodone-Acetaminophen | 15 | $54 | $4 |
| Tramadol | 17 | $40 | $2 |
2021: 3 drugs
| Narcan | 12 | $1,577 | $131 |
| Diclofenac | 23 | $574 | $25 |
| Tramadol | 18 | $37 | $2 |
2019: 10 drugs
| Symbicort | 15 | $4,642 | $309 |
| Levetiracetam | 12 | $537 | $45 |
| Atorvastatin | 26 | $296 | $11 |
| Fluticasone Propionate | 15 | $225 | $15 |
| Trazodone | 24 | $213 | $9 |
| Levothyroxine | 14 | $205 | $15 |
| Amitriptyline | 13 | $153 | $12 |
| Metformin | 12 | $113 | $9 |
| Lisinopril | 16 | $111 | $7 |
| Amlodipine Besylate | 12 | $69 | $6 |
2018: 13 drugs
| Lyrica | 18 | $7,684 | $427 |
| Ventolin Hfa | 21 | $1,149 | $55 |
| Levetiracetam | 20 | $593 | $30 |
| Polyethylene Glycol 3350 | 11 | $307 | $28 |
| Atorvastatin | 14 | $271 | $19 |
| Gabapentin | 15 | $261 | $17 |
| Metoprolol | 15 | $239 | $16 |
| Lisinopril | 26 | $149 | $6 |
| Levothyroxine | 12 | $138 | $11 |
| Metformin | 15 | $110 | $7 |
| Metoprolol | 13 | $97 | $7 |
| Furosemide | 14 | $63 | $5 |
| Amlodipine Besylate | 12 | $46 | $4 |
Money from drug and device companies
$20 in 2024
| 2024 | 1 | 1 | None | $20 |
| 2023 | 2 | 36 | None | $841 |
| 2022 | 3 | 55 | None | $1,203 |
| 2021 | 3 | 29 | None | $761 |
| 2020 | 3 | 7 | None | $371 |
| 2019 | 2 | 4 | None | $358 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Masimo | Patient Safetynet System | $20 | 1 payment
|
See the published payment
| Masimo | Meals · 2024-01-09 | Patient Safetynet System | $20 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $841
| Medtronic | Kyphon Express II Kyphopak Tray | $818 | 35 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $23 | 1 payment
|
2022: $1,203
| Boston Scientific | Wavewriter Alpha Prime 16 | $743 | 32 payments
|
| Medtronic | None | $439 | 22 payments
|
| Hikma Pharmaceuticals USA | Kloxxado | $21 | 1 payment
|
2021: $761
| Medtronic | Intellis | $444 | 17 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $164 | 2 payments
|
| Boston Scientific | General Pain Management | $152 | 10 payments
|
2020: $371
| Boston Scientific | Infinion | $176 | 2 payments
|
| Avanos Medical | Generator | $129 | 2 payments
|
| Medtronic USA | Intellis | $66 | 3 payments
|
2019: $358
| Boston Scientific | General Pain Management | $196 | 2 payments
|
| Medtronic USA | Intellis | $162 | 2 payments
|
Professional record
- NPI
- 1689036824
- Licence
- CA A151701California A151701: Current · expires 2028-11-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208VP0014X (208VP0014X)
- Mailing address
- 38437 Mission Blvd Ste 101, Fremont, CA, 94536
- NPI first listed
- 2016-03-27
- NPI last updated
- 2021-03-23
- NPI record certified
- 2021-03-23
This is when the NPI record was last certified, not a medical board exam.